Date of this Version


Document Type

Journal Article

Publication Details

Published version.

Jayasinghe, R., & Kostner, K. M. (2009). Lp(a) and coronary disease: Rules of engagement - when to measure and how to treat. South African Medical Journal, 99(7), 502-504.

Access the Journal's homepage.

2009 HERDC submission. FoR code: 1102; 1103

© Copyright SAMJ, 2009


Lipoprotein (a) (Lp(a)) has been described as an important component of the lipid profile and a significant coronary risk factor when elevated. Controversy surrounds the importance of this lipoprotein variant, and its management is often challenging for clinicians. Important issues relate to the control and management of high Lp(a) levels, especially in patients at intermediate risk of cardiovascular disease. Clear guidelines are lacking on who needs Lp(a) measured, and when. We review practical points on investigating and managing Lp(a).



This document has been peer reviewed.


To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.